ArticleBMC clinical pathology2012

Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization.

Jens Mollerup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.